Migraine inhibitor olcegepant reduces weight loss and IL-6 release in SARS-CoV-2-infected older mice with neurological signs.
Article in Journal of Virology (May 2024)
The most recent citing publications are shown below. View all 3 publications that cite this research output on Dimensions.
Migraine inhibitor olcegepant reduces weight loss and IL-6 release in SARS-CoV-2 infected older mice with neurological signs
Preprint in bioRxiv (October 2023)
COVID-19 And Contributions from Animal-based Research.
Article in Comparative Medicine (February 2023)